Aflatoxin M1 Detoxification Ability of Probiotic Lactobacilli of Indian Origin in In vitro Digestion Model
- 14 Downloads
Aflatoxin M1 (AFM1) is known to be a potent carcinogen and continues to pose a public health concern through the consumption of contaminated dairy foods. It is anticipated that consumption of lactic acid bacteria capable of binding aflatoxins can reduce the risk of AFM1 on human health to a certain extent. Seldom reports have hinted the possibility of using lactic acid bacteria for the biological detoxification of AFM1. Hence, the present study was conducted to assess the ability of selected probiotic Lactobacillus strains for their AFM1 binding ability in PBS and to reduce its bioaccessibility in artificially contaminated skim milk using an in vitro digestion model. Eleven tested probiotic strains illustrated various degrees of AFM1 binding ability ranging from 4.13 to 64.16%. Five among the 11 probiotic strains were subsequently selected for detailed studies on the basis of highest binding potential after 24 h of incubation period. The stability of bacterial-AFM1 complex was assessed by repeated washings with AFM1 free PBS. The observation on bacterial-AFM1 complex stability showed small release of AFM1 in first and second wash (17.30 to 0.98%) where as none was detectable in the third wash. However, upon chloroform extraction, 88.57 to 92.30% of bound AFM1 was released from the bacterial cells which indicate AFM1 binding to the bacterial cell surface rather than absorption or degradation of AFM1 by bacterial cells. During the in vitro digestion test in skim milk, bioaccessibility of AFM1 was reduced to a scale of 32.61 to 52.84% in the presence of selected strains of probiotic lactobacilli. The present findings suggest that selected probiotic strains could be potentially used to mitigate the toxic effects of AFM1 in the contaminated milk and milk products and thereby enhance food safety.
KeywordsAflatoxin M1 Lactobacillus Probiotics ELISA Bioaccessibility Food safety
Financial and logistical supports were provided by the Director of ICAR-National Dairy Research Institute, Karnal-132001, Haryana, India.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that there are no conflicts of interest.
- 4.Knipstein B, Huang J, Barr E, Sossenheimer P, Dietzen D, Egner PA, Groopman JD, Rudnick DA (2015) Dietary aflatoxin-induced stunting in a novel rat model: evidence for toxin-induced liver injury and hepatic growth hormone resistance. Pediatr Res 78(2):120–127. https://doi.org/10.1038/pr.2015.84 CrossRefGoogle Scholar
- 8.IARC, International Agency for Research on Cancer (2002b) Some traditional herbal medicines, some mycotoxins, naphthalene and styrene, IARC Monogr Eval Carcinog Risk Hum. IARC Press, Lyon, pp 1–556Google Scholar
- 10.European Commission (2006) Commission regulation (EC) no. 401/ 2006 of 23 February 2006 laying down the methods of sampling and analysis for the official control of the levels of mycotoxins in foodstuffs (text with EEA relevance). Off J Eur Union L70:12–34Google Scholar
- 20.Serrano-Nino JC, Cavazos-Garduno A, Hernandez-Mendoza A, Applegate B, Ferruzzi MG, San Martin-Gonzalez MF, Garcia HS (2013) Assessment of probiotic strains ability to reduce the bioaccessibility of aflatoxin M1 in artificially contaminated milk using an in vitro digestive model. Food Cont 31(1):202–207. https://doi.org/10.1016/j.foodcont.2012.09.023 CrossRefGoogle Scholar
- 22.Avantaggiato G, Havenaar R, Visconti A (2004) Evaluation of the intestinal absorption of deoxynivalenol and nivalenol by an in vitro gastrointestinal model, and the binding efficacy of activated carbon and other adsorbent materials. Food Chem Toxicol 42(5):817–824. https://doi.org/10.1016/j.fct.2004.01.004 CrossRefGoogle Scholar
- 24.Kabak B, Brandon EFA, Var I, Blokland M, Sips AJAM (2009) Effects of probiotic bacteria on the bioaccessibility of aflatoxin B1 and ochratoxin A using an in vitro digestion model under fed conditions. J Environ Sci Health B 44(5):472–480. https://doi.org/10.1080/03601230902935154 CrossRefGoogle Scholar
- 34.Marhamatizadeh MH, Goosheh SR (2016) The combined effect of Thymus vulgaris extract and probiotic bacteria (Lactobacillus acidophilus and Bifidobacterium bifidum) on aflatoxin M1 concentration in kefir beverage. Ital J Food Sci 28(3):517–524. https://doi.org/10.14674/1120-1770/ijfs.v244 Google Scholar
- 35.Sarlak Z, Rouhi M, Mohammadi R, Khaksar R, Mortazavian AM, Sohrabvandi S, Garavand F (2017) Probiotic biological strategies to decontaminate aflatoxin M1 in a traditional Iranian fermented milk drink (Doogh). Food Cont 71:152–159. https://doi.org/10.1016/j.foodcont.2016.06.037 CrossRefGoogle Scholar
- 39.Sarimehmetoglu B, Kuplulu O (2004) Binding ability of aflatoxin M1 to yoghurt bacteria. Ank Univ Vet Fak Derg 51:195–198Google Scholar
- 46.Shahin AAM (2007) Removal of aflatoxin B1 from contaminated liquid media by dairy lactic acid bacteria. Int J Agri Biol 9:71–75Google Scholar
- 49.Serrano-Nino JC, Cavazos-Garduno A, Cantu-Cornelio F, Gonzalez-Cordova AF, Vallejo-Cordoba B, Hernandez-Mendoza A, Garcia HS (2015) In vitro reduced availability of aflatoxin B1 and acrylamide by bonding interactions with teichoic acids from Lactobacillus strains. LWT Food Sci Technol 64(2):1334–1341. https://doi.org/10.1016/j.lwt.2015.07.015. CrossRefGoogle Scholar
- 50.Kabak B, Ozbey F (2012) Assessment of the bioaccessibility of aflatoxins from various food matrices using an in vitro digestion model, and the efficacy of probiotic bacteria in reducing bioaccessibility. J Food Compost Anal 27(1):21–31. https://doi.org/10.1016/j.jfca.2012.04.006 CrossRefGoogle Scholar